NAFLD and cardiovascular risk: Direct evidence for the tale of two ages

American Journal of Gastroenterology

Volumn 104, Issue 7, 2009, Pages 1851-1852

  Lonardo, Amedeo ^a   Loria, Paola ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; HUMAN; LETTER; LIVER DISEASE; METABOLIC SYNDROME X; MORTALITY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL;

AGE FACTORS; CARDIOVASCULAR DISEASES; COMORBIDITY; CONFIDENCE INTERVALS; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NEEDS ASSESSMENT; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 67650469181     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.233     Document Type: Letter

References (4)

1. Qadeer MA, Vargo JJ. BIS: hit or miss? Am J Gastroenterol 2009; 104: 1850 (this issue).
2. von Delius S, Thies P, Rieder S et al. Auditory evoked potentials compared with bispectral index for monitoring of midazolam and propofol sedation during colonoscopy. Am J Gastroenterol 2009;104:38-25.
3. Qadeer MA, Vargo JJ, Patel S et al. Bispectral index monitoring of conscious sedation with the combination of meperidine and midazolam during endoscopy. Clin Gastroenterol Hepatol 2008;6:102-8.
4. Cohen LB, Hightower CD, Wood DA et al. Moderate level sedation during endoscopy: a prospective study using low-dose propofol, meperidine/fentanyl, and midazolam. Gastroin-test Endosc 2004;59:795-803.